SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,302,714 | -56.2% | 63,300 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $2,976,366 | +12.1% | 63,300 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $2,656,068 | +261.4% | 63,300 | +644.7% | 0.00% | +300.0% |
| Q4 2020 | $735,000 | -19.4% | 8,500 | -43.1% | 0.00% | -50.0% |
| Q3 2020 | $912,000 | +8.7% | 14,926 | -26.0% | 0.00% | 0.0% |
| Q2 2020 | $839,000 | +1578.0% | 20,179 | +2422.4% | 0.00% | – |
| Q3 2017 | $50,000 | -71.4% | 800 | -63.6% | 0.00% | – |
| Q2 2017 | $175,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |